Icu Medical (ICUI) Net Income towards Common Stockholders (2009 - 2026)

Icu Medical has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $30.7 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 298.62% year-over-year to $30.7 million; the trailing twelve-month figure through Mar 2026 stood at $48.1 million (up 151.38% YoY), and the FY2025 full-year result was $1.9 million, up 101.63% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $30.7 million, up from -$13.2 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $32.5 million in Q2 2025, with the low at -$39.5 million in Q1 2024.
• Historically, Net Income towards Common Stockholders has averaged -$11.1 million across 5 years, with a median of -$13.2 million in 2025.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders slumped 555.69% — and 2026, when it jumped 298.62%.
• Icu Medical's Net Income towards Common Stockholders stood at -$15.5 million in 2022, then retreated by 10.37% to -$17.1 million in 2023, then plunged by 38.96% to -$23.8 million in 2024, then jumped by 44.4% to -$13.2 million in 2025, then jumped by 332.01% to $30.7 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $30.7 million (Q1 2026), -$13.2 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.